EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Prevalence and predictors of viral load non-suppression among adolescents on dolutegravir-based antiretroviral therapy: A cross-sectional study from three urban clinics, Soroti City

Connie Nait iD, Simple Ouma, Saadick Mugerwa Ssentongo, Boniface Oryokot, Abraham Ignatius Oluka, Raymond Kusiima, Victoria Nankabirwa, John Bosco Isunju

PLOS One · 2025

DOI: 10.1371/journal.pone.0331835 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS One, 2025. Verfasst von Connie Nait und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Heterocyclic Compounds, 3-Ring, Viral Load, HIV Infections, Anti-HIV Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite advances in HIV care, viral load suppression (VLS) among adolescents living with HIV (ALHIV) in Uganda continue to lag behind that of adults, even with the introduction of dolutegravir (DTG)-based regimens, the Youth and Adolescent Peer Supporter (YAPS) model, and community-based approaches. Understanding factors associated with HIV viral load non-suppression in this population is critical to inform HIV treatment policy. This study assessed the prevalence and predictors of viral load non-suppression among ALHIV aged 10–19 years on DTG-based ART in Soroti City, Uganda.

Methods

We conducted a cross-sectional study among 447 ALHIV attending three urban HIV clinics in Soroti City. Data were abstracted using a structured questionnaire and analyzed in STATA 15.0. Modified Poisson regression with robust error variance was used to identify predictors of viral load non-suppression. Adjusted relative risks (aRR) and 95% confidence intervals (CIs) were reported, with statistical significance set at p ≤ 0.05.

Results

Of the 447 participants, 53.5% were female, with a median age of 16 years (IQR: 14.0–17.6). The majority (72.9%) were from Soroti district and had been on DTG-based ART for a median of 42.5 months (IQR: 37.0–48.0). Most were receiving multi-month dispensing (MMD) (75.2%) and were active in care (98%). The prevalence of viral load non-suppression was 19.2% (86/447). Independent predictors of non-suppression included older age (15–19 vs. 10–14 years) (aRR: 1.69; 95% CI: 1.08–2.67), male sex (aRR: 1.48; 95% CI: 1.05–2.11), prior non-suppression before switching to DTG (aRR: 1.76; 95% CI: 1.19–2.59), use of non-fixed dose DTG regimens (aRR: 2.03; 95% CI: 1.23–3.33), history of poor adherence (aRR: 4.36; 95% CI: 2.05–9.26), and not receiving MMD (aRR: 2.83; 95% CI: 1.93–4.15).

Conclusion

Nearly one in five adolescents on DTG-based ART in Soroti City had viral non-suppression, despite optimized treatment regimens. Targeted interventions−particularly enhanced adherence counseling for older and male adolescents, expanding MMD coverage, and provision of fixed-dose regimens−are urgently needed to improve VLS among ALHIV. These findings underscore the need for adolescent-centered HIV care strategies to close the viral suppression gap and advance progress towards epidemic control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heterocyclic Compounds, 3-RingViral LoadHIV InfectionsAnti-HIV AgentsHumansAdolescentPyridonesMaleFemaleOxazinesCross-Sectional StudiesPiperazinesYoung AdultUgandaPrevalenceChildHIV Integrase InhibitorsDolutegravir

Substanzen

PyridonesOxazinesHeterocyclic Compounds, 3-RingPiperazinesHIV Integrase InhibitorsAnti-HIV AgentsDolutegravir

Autor:innen und Institutionen

  • School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Directorate of Research and Capacity Development, The AIDS Support Organization, Kampala, Uganda.
  • Directorate of Program Management and Capacity Development, AIDS Information Center, Kampala, Uganda.

ORCID-Profile: Connie Nait

Zitieren

APA

Nait, C., Ouma, S., Ssentongo, S. M., Oryokot, B., Oluka, A. I., Kusiima, R., Nankabirwa, V., & Isunju, J. B. (2025). Prevalence and predictors of viral load non-suppression among adolescents on dolutegravir-based antiretroviral therapy: A cross-sectional study from three urban clinics, Soroti City. PLOS One. https://doi.org/10.1371/journal.pone.0331835

Vancouver

Nait C, Ouma S, Ssentongo SM, Oryokot B, Oluka AI, Kusiima R, et al. Prevalence and predictors of viral load non-suppression among adolescents on dolutegravir-based antiretroviral therapy: A cross-sectional study from three urban clinics, Soroti City. PLOS One. 2025. doi:10.1371/journal.pone.0331835

BibTeX
@article{Nait2025,
  author = {Nait, Connie and Ouma, Simple and Ssentongo, Saadick Mugerwa and Oryokot, Boniface and Oluka, Abraham Ignatius and Kusiima, Raymond and Nankabirwa, Victoria and Isunju, John Bosco},
  title = {Prevalence and predictors of viral load non-suppression among adolescents on dolutegravir-based antiretroviral therapy: A cross-sectional study from three urban clinics, Soroti City},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331835}
}
Kostenlos starten →